News Archives

This is the archive of news updates from the Fuji Pharma website.
Click on each news item to view the full details.

2024.02.08
Financial Results(決算資料): Financial Results of 1Q/FY2024
2024.01.29
Release(リリース): Succession of Manufacturing and Marketing Approval for Three Products from Mitsubishi Tanabe Pharma
2023.12.11
Financial Results(決算資料): Script for Business Results Briefing for the Fiscal Year Ended September 30, 2023
2023.11.28
Other(その他): Notice of the 59th Ordinary General Meeting of Shareholders
2023.11.20
Financial Results(決算資料): Business Results of FY2023
2023.11.09
Financial Results(決算資料): Supplemental Materials of FY2023 Consolidated Financial Results
2023.11.09
Financial Results(決算資料): Financial Results of FY2023
2023.10.18
Release(リリース): Submission of a Marketing Approval Application for FSN-013 in Japan
2023.09.25
Release(リリース): Marketing Approval for Ustekinumab Biosimilar
2023.09.06
Release(リリース): Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen's Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan